Losartan in Treating Patients With Idiopathic Pulmonary Fibrosis
Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Losartan may be effective in treating patients with idiopathic pulmonary fibrosis.
PURPOSE: This clinical trial is studying the side effects of losartan and to see how well it
works in treating patients with idiopathic pulmonary fibrosis.